Thoratec heart device to face panel review

11/28/2007 | Forbes

The FDA has asked an outside panel of cardiac experts to review the effectiveness of Thoratec Corp.'s HeartMate II, a mechanical heart pump designed for heart failure patients awaiting transplants, before granting its approval. Analysts expect HeartMate II to receive a favorable review despite not reaching a key effectiveness goal in a company study.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ